Difference between revisions of "Part:BBa K3610022:Design"
(→References) |
(→Source) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 8: | Line 8: | ||
===Design Notes=== | ===Design Notes=== | ||
none | none | ||
| − | |||
| − | |||
===Source=== | ===Source=== | ||
| − | + | Cyril Zipfel Lab at UZH, Switzerland | |
===References=== | ===References=== | ||
Latest revision as of 23:12, 27 October 2020
FKBP
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
none
Source
Cyril Zipfel Lab at UZH, Switzerland
References
Inobe T, Nukina N. Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins. J Biosci Bioeng. 2016;122(1):40-46. doi:10.1016/j.jbiosc.2015.12.004
Kolos, Jürgen M.; Voll, Andreas M.; Bauder, Michael; Hausch, Felix (2018): FKBP Ligands—Where We Are and Where to Go? In: Frontiers in Pharmacology 9, S. 1425. DOI: 10.3389/fphar.2018.01425.